# EDGAR Filing Document

**Accession Number:** 0001832466
**File Stem:** 0001628280-25-058559
**Filing Date:** 2025-12
**Character Count:** 22613
**Document Hash:** 1ced8033c06f9fc9499817851e2a03e2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-058559.hdr.sgml**: 20251222

**ACCESSION NUMBER**: 0001628280-25-058559

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 14

**FILED AS OF DATE**: 20251222

**DATE AS OF CHANGE**: 20251222

**EFFECTIVENESS DATE**: 20251222

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Alignment Healthcare, Inc.
- **CENTRAL INDEX KEY:** 0001832466
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOSPITAL & MEDICAL SERVICE PLANS [6324]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 465596242
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292370
- **FILM NUMBER:** 251592994

**BUSINESS ADDRESS:**
- **STREET 1:** 1100 W. TOWN AND COUNTRY ROAD
- **STREET 2:** SUITE 1600
- **CITY:** ORANGE
- **STATE:** CA
- **ZIP:** 92868
- **BUSINESS PHONE:** 844-310-2247

**MAIL ADDRESS:**
- **STREET 1:** 1100 W. TOWN AND COUNTRY ROAD
- **STREET 2:** SUITE 1600
- **CITY:** ORANGE
- **STATE:** CA
- **ZIP:** 92868

**As filed with the Securities and Exchange Commission on December 22, 2025** 

**Registration No. 333-** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM S-8** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

**ALIGNMENT HEALTHCARE, INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **46-5596242** |
| **(State or other jurisdiction of <br>incorporation or organization)** | **(I.R.S. Employer Identification No.)** |
| **1100 W. Town and Country Road, Suite 1600<br>Orange, California** | **92868** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Alignment Healthcare, Inc. 2021 Equity Incentive Plan** 

**(Full title of the plan)** 

**John Kao** 

**Chief Executive Officer** 

**1100 W. Town and Country Road** 

**Suite 1600** 

**Orange, California 92868** 

**Telephone: 1-844-310-2247** 

**(Name, address and telephone number, including area code, of agent for service)** 

***Copies to:***

**Christopher J. Cummings** 

**Paul, Weiss, Rifkind, Wharton & Garrison LLP** 

**1285 Avenue of the Americas** 

**New York, NY 10019-6064** 

**(212) 373-3000** 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

------

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**PART I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS** 

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Plan Information.**

The documents containing the information specified in Part I will be delivered in accordance with Rule 428(b) under the Securities Act of 1933, as amended (the "Securities Act"). Such documents are not required to be, and are not, filed with the Securities and Exchange Commission (the "Commission"), either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. These documents, and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of the Form S-8, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Registrant Information and Employee Plan Annual Information.**

The written statement required by Item 2 of Part I is included in documents that will be delivered to participants in the plan covered by this Registration Statement pursuant to Rule 428(b) of the Securities Act.

**PART II** 

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

*In this Registration Statement, Alignment Healthcare, Inc. is sometimes referred to as the "Registrant," "we," "us" or "our."* 

**REGISTRATION OF ADDITIONAL SECURITIES** 

**PURSUANT TO GENERAL INSTRUCTION E OF FORM S-8** 

This Registration Statement on Form S-8 is filed by the Registrant, relating to 27,915,561 shares of its common stock, $0.001 par value (the "Common Stock"), issuable to eligible employees, directors and consultants of the Registrant under the Registrant's 2021 Equity Incentive Plan (the "Equity Plan"). Shares available for issuance under the Equity Plan were previously registered on a registration statement on Form S-8 filed with the SEC on March 31, 2021, Registration No. 333-254887 (the "Prior Registration Statement"). The Prior Registration Statement is currently effective. In accordance with Section E of the General Instructions to Form S-8, the contents of the Prior Registration Statement are incorporated herein by reference, except to the extent supplemented, amended or superseded by the information set forth herein.

**Item 3. Incorporation of Documents by Reference.** 

The SEC allows us to incorporate by reference the information we file with them, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this Registration Statement, and later information filed with the SEC will update and supersede this information. We hereby incorporate by reference into this Registration Statement the following documents previously filed with the SEC:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the contents of our earlier <u>[Registration Statement](https://www.sec.gov/Archives/edgar/data/1832466/000119312521100879/d161922ds8.htm)[on Form S-8](https://www.sec.gov/Archives/edgar/data/1832466/000119312521100879/d161922ds8.htm)</u> relating to the Equity Plan, previously filed with the SEC on March 31, 2021 (File No. 333-254887);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our <u>[Annual Report on Form 10-K](https://www.sec.gov/Archives/edgar/data/1832466/000162828025008730/alhc-20241231.htm)</u> for the year ended December 31, 2024, filed with the SEC on February 27, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our <u>[Quarterly Report on Form 10-Q](https://www.sec.gov/Archives/edgar/data/1832466/000162828025047538/alhc-20250930.htm)</u> for the fiscal quarter ended September 30, 2025, filed with the SEC on October 30, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our <u>[Quarterly Report on Form 10-Q](https://www.sec.gov/Archives/edgar/data/1832466/000162828025036713/alhc-20250630.htm)</u> for the fiscal quarter ended June 30, 2025, filed with the SEC on July 30, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our <u>[Quarterly Report on Form 10-Q](https://www.sec.gov/Archives/edgar/data/1832466/000162828025021571/alhc-20250331.htm)</u> for the fiscal quarter ended March 31, 2025, filed with the SEC on May 1, 2025;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• portions of our <u>[Definitive Proxy Statement on Schedule 14A](https://www.sec.gov/Archives/edgar/data/1832466/000162828025019952/alhc-20250425.htm)</u> filed with the SEC on April 25, 2025 that are incorporated by reference into Part III of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our Current Reports on Form 8-K filed with the SEC on <u>[January 13, 2025](https://www.sec.gov/Archives/edgar/data/1832466/000162828025001253/alhc-20250113.htm)</u> (Item 5.02 thereof), <u>[April 15, 2025](https://www.sec.gov/Archives/edgar/data/1832466/000162828025017872/alhc-20250409.htm)</u> and <u>[June 11, 2025](https://www.sec.gov/Archives/edgar/data/1832466/000162828025030795/alhc-20250605.htm)</u>; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the description of our common stock set forth in <u>[Exhibit 4.2](https://www.sec.gov/Archives/edgar/data/1832466/000095017022002810/alhc-ex4_2.htm)</u> to our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 3, 2022.

All reports and other documents that the Registrant subsequently files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment to the Registration Statement which indicates that all of the shares of Common Stock offered hereby have been sold or which deregisters all of such shares then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents, except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, that is not deemed filed under such provisions in accordance with the rules of the Commission. For the purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Under no circumstances will any information filed under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

**Item 8.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.**

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit <br>Number** | **Description** |
| 4.1 | <u>[Amended and Restated Certificate of Incorporation of Alignment Healthcare, Inc.](https://www.sec.gov/Archives/edgar/data/1832466/000119312521100476/d292883dex31.htm)</u> (incorporated by reference to Exhibit 3.1 to the Registrant's Form 8-K filed on March 30, 2021) |
| 4.2 | <u>[Certificate of Amendment to Amended and Restated Certificate of Incorporation dated June 11, 2024](https://www.sec.gov/Archives/edgar/data/1832466/000162828024027889/certificateofamendment-alh.htm)</u> (incorporated by reference to Exhibit 99.1 to the Registrant's Form 8-K filed on June 13, 2024) |
| 4.3 | <u>[Amended and Restated Bylaws of Alignment Healthcare, Inc.](https://www.sec.gov/Archives/edgar/data/1832466/000095017024021154/alhc-ex3_2.htm)</u> (incorporated by reference to Exhibit 3.2 to the Registrant's Form 10-K filed on February 27, 2024) |
| 4.4# | <u>[Alignment Healthcare, Inc. 2021 Equity Incentive Plan](https://www.sec.gov/Archives/edgar/data/1832466/000119312521100476/d292883dex102.htm)</u> (incorporated by reference to Exhibit 10.2 to the Registrant's Form 8-K filed March 30, 2021) |
| 5.1\* | <u>[Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP](alhc-legalityopinionpwdraf.htm)</u> |
| 23.1\* | <u>[Consent of Deloitte LLP](deloitteconsent-sx812_19x2.htm)</u> |
| 23.2\* | <u>[Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP](alhc-legalityopinionpwdraf.htm)</u> (included in Exhibit 5.1) |
| 24.1\* | <u>[Power of Attorney](#ic1992ce3cef447daa8ed83e7894ff572_60)</u> (included on signature page) |
| 107.1\* | <u>[Filing Fee Table](exfilingfees.htm)</u> |

---

\* Filed herewith.

# Indicates management contract or compensatory plan.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Orange, State of California, on December 22, 2025.

---

| | |
|:---|:---|
| ALIGNMENT HEALTHCARE, INC. | ALIGNMENT HEALTHCARE, INC. |
| By: | /s/ John Kao |
|  | **John Kao** |
|  | **Chief Executive Officer** |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below hereby constitutes and appoints each of John Kao and James M. Head, acting singly, his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration statement or any such amendment, and (iv) take any and all actions which may be necessary or appropriate in connection therewith, granting unto such agents, proxies and attorneys-in-fact, and each of them, full power and authority to do and perform each and every act and thing necessary or appropriate to be done, as fully for all intents and purposes as he might or could do in person, hereby approving, ratifying and confirming all that such agents, proxies and attorneys-in-fact or any of their substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on December 22, 2025.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ John Kao | Chief Executive Officer <br>(Principal Executive Officer) | December 22, 2025 |
| **John Kao** |  |  |
| /s/ James M. Head | Chief Financial Officer (Principal Financial Officer) | December 22, 2025 |
| **James M. Head** |  |  |
| /s/ Joseph Konowiecki | Chairman of the Board | December 22, 2025 |
| **Joseph Konowiecki** |  |  |
| /s/ Jody Bilney | Director | December 22, 2025 |
| **Jody Bilney** |  |  |
| /s/ David Hodgson | Director | December 22, 2025 |
| **David Hodgson** |  |  |
| /s/ Yon Jorden | Director | December 22, 2025 |
| **Yon Jorden** |  |  |

---

------

---

| | | |
|:---|:---|:---|
| /s/ Jacqueline Kosecoff | Director | December 22, 2025 |
| **Jacqueline Kosecoff** |  |  |
| /s/ Margaret McCarthy | Director | December 22, 2025 |
| **Margaret McCarthy** |  |  |
| /s/ Mark McClellan | Director | December 22, 2025 |
| **Mark McClellan** |  |  |
| **/s/** Robbert Vorhoff | Director | December 22, 2025 |
| **Robbert Vorhoff** |  |  |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? exfilingfees

**Exhibit 107.1**

**Calculation of Filing Fee Table**

**Form S-8**

(Form Type)

**Alignment Healthcare, Inc.**

(Exact Name of Registrant as Specified in its Charter)

**Table 1 — Newly Registered Securities**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
| Equity | Common stock, $0.001 par value per share | Rule 457(c) and Rule 457(h) | 27915561<sup>(1)</sup> | 19.80<sup>(2)</sup> | $552728108 | $0.0001381 | $76332 |
| Total Offering Amounts | Total Offering Amounts | Total Offering Amounts | Total Offering Amounts |  | $552728108 |  | $76332 |
| Total Fee Offsets<sup>(3)</sup> | Total Fee Offsets<sup>(3)</sup> | Total Fee Offsets<sup>(3)</sup> | Total Fee Offsets<sup>(3)</sup> |  |  |  | $— |
| Net Fee Due | Net Fee Due | Net Fee Due | Net Fee Due |  |  |  | $76332 |

---

(1) Represents the maximum number of shares of common stock issuable pursuant to Alignment Healthcare, Inc.'s (the "Registrant") 2021 Equity Incentive Plan (the "Equity Plan") not previously registered on Form S-8, including shares of Common Stock that will be automatically added to the shares authorized for issuance under the Equity Plan on January 1, 2026 pursuant to the "evergreen" provision contained in the Equity Plan. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall also cover any additional shares of the Registrant's common stock that become issuable under the Equity Plan by reason of any stock dividend, stock split, recapitalization or similar transaction effected without the Registrant's receipt of consideration which would increase the number of outstanding shares of common stock.

(2) Estimated in accordance with Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $19.80 per share, which is the average of the high and low prices of Common Stock on December 15, 2025, as reported on the Nasdaq Global Select Market.

(3) The Registrant does not have any fee offsets.

## Exhibit 5.1

**Exhibit 5.1**

---

| | |
|:---|:---|
| PAUL, WEISS, RIFKIND, WHARTON & GARRISON LLP | Brussels<br>Hong Kong<br>London<br>Los Angeles<br>San Francisco<br>Tokyo<br>Toronto<br>Washington, DC<br>Wilmington |
| 1285 Avenue of the Americas<br>New York, NY 10019-6064<br>+1 212 373 3000 | Brussels<br>Hong Kong<br>London<br>Los Angeles<br>San Francisco<br>Tokyo<br>Toronto<br>Washington, DC<br>Wilmington |
|  | Brussels<br>Hong Kong<br>London<br>Los Angeles<br>San Francisco<br>Tokyo<br>Toronto<br>Washington, DC<br>Wilmington |

---

December 22, 2025

Alignment Healthcare, Inc. <br>1100 W. Town and Country Road,<br>Suite 1600<br>Orange, CA 92868

<u>Registration Statement on Form S-8</u>

Ladies and Gentlemen:

We have acted as special counsel to Alignment Healthcare, Inc., a Delaware corporation (the "Company"), in connection with the Registration Statement on Form S-8 (the "Registration Statement") of the Company, filed with the Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended (the "Act"), and the rules and regulations thereunder (the "Rules"). You have asked us to furnish our opinion as to the legality of the securities being registered under the Registration Statement. The Registration Statement relates to the registration under the Act of 27,915,561 shares of common stock, par value $0.001 per share, of the Company (collectively, the "Shares"), that are reserved for issuance under the Alignment Healthcare, Inc. 2021 Equity Incentive Plan (the "Plan").

In connection with the furnishing of this opinion, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (collectively, the "Documents"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.the Registration Statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.the Plan and the forms of award agreements (the "Plan Agreements") relating to awards under the Plan.

In addition, we have examined (i) such corporate records of the Company that we have considered appropriate, including a copy of the Amended and Restated Certificate of Incorporation of the Company and the Amended and Restated Bylaws of the Company, each certified by the Company as in effect on the date of this letter, and copies of resolutions of the board of directors of the Company relating to the issuance of the Shares, certified by the Company and (ii) such other certificates, agreements and documents that we deemed relevant and necessary as a basis for the opinion expressed below. We have also relied upon certificates of public officials and the officers of the Company.

In our examination of the documents referred to above, we have assumed, without independent investigation, the genuineness of all signatures, the legal capacity of all individuals who have executed any of the documents reviewed by us, the authenticity of all documents submitted to us as originals, the conformity to the originals of all documents submitted to us as certified, photostatic, reproduced or conformed copies of valid existing agreements or other documents, the authenticity of all the latter documents and that the statements regarding matters of fact in the certificates, records, agreements, instruments and documents that we have examined are accurate and complete.

Based upon the above, and subject to the stated assumptions, exceptions and qualifications, we are of the opinion that the Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued and delivered in accordance with the terms of the Plan and any applicable Plan Agreement, the Shares will be validly issued, fully paid and non-assessable.

The opinion expressed above is limited to the General Corporation Law of the State of Delaware. Our opinion is rendered only with respect to the laws, and the rules, regulations and orders under those laws, that are currently in effect.

We hereby consent to use of this opinion as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required by the Act or the Rules.

------

Very truly yours,

/s/ Paul, Weiss, Rifkind, Wharton & Garrison LLP<br>PAUL, WEISS, RIFKIND, WHARTON & GARRISON LLP

## Exhibit 23.1

**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 27, 2025 relating to the financial statements of Alignment Healthcare, Inc. and the effectiveness of Alignment Healthcare, Inc.'s internal control over financial reporting, appearing in the Annual Report on Form 10-K of Alignment Healthcare, Inc. for the year ended December 31, 2024.

/s/ Deloitte & Touche LLP

Costa Mesa, California

December 22, 2025

<br>